July 8 2013 | By Márcio Barra
It’s no secret that clinical research in Portugal has, from year to year, been losing clinical trials to other countries. As seen on Pharmupdates original article “The current state of Clinical trials in Portugal”, the reasons to blame are many, and this lack of investment is hurting the country.
PwC, in Partnership with Apifarma has developed an in depth report entitled “Ensaios Clínicos em Portugal”, launched this past June and received with quite a lot of expectations here at Pharmupdates, as it sheds more light in this matter. This report (in Portuguese) details the clinical trial activity in Portugal to try and understand its importance in the Portuguese economy, identify the main barriers to their progress and outline a set of proposals to overcome the identified limitations.
pharmupdates.wordpress.com 